Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cell Specific Gene Expression

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...

Hepatic Drug Excretion: Influencing Factors

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...

Hepatic Drug Clearance: Effect of Protein Binding

Hepatic Drug Clearance: Effect of Protein Binding

Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Characterization of complex environmental contaminant mixtures in common toad breeding ponds in Flanders, Belgium.

Environmental pollution (Barking, Essex : 1987)·2026

Same author

Preface to the dedicated issue of the first TRACES conference (Residues of pharmacologically active substances in food, feed and environment, within the One Health concept), held in Ghent from June 3 to 6, 2025.

Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment·2026

Same author

The Gordon Memorial Lecture: Steering the gut microbiome for improved health and welfare in broilers.

British poultry science·2025

Same author

International interlaboratory study to normalize liquid chromatography-based mycotoxin retention times through implementation of a retention index system.

Journal of chromatography. A·2025

Same author

Agricultural contaminants in amphibian breeding ponds: Occurrence, risk and correlation with agricultural land use.

The Science of the total environment·2021

Same author

A field study on correlations between macroscopic gut health scoring, histological measurements and performance parameters in broilers.

Avian pathology : journal of the W.V.P.A·2021

Search research articles

Related Experiment Video

Updated: May 15, 2026

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

Hepatic and intestinal CYP3A expression and activity in broilers.

A Osselaere¹, L De Bock, V Eeckhaut

¹Department of Pharmacology, Toxicology and Biochemistry, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium.

Journal of Veterinary Pharmacology and Therapeutics

|January 22, 2013

Summary

This summary is machine-generated.

Broiler chickens exhibit significant cytochrome P450 (CYP3A37) expression and activity in the small intestine, particularly the duodenum and jejunum, highlighting its role in drug metabolism.

More Related Videos

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Published on: March 28, 2017

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology

Published on: March 14, 2020

Related Experiment Videos

Last Updated: May 15, 2026

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Published on: March 28, 2017

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology

Published on: March 14, 2020

Area of Science:

Pharmacology
Veterinary Medicine
Biochemistry

Background:

Cytochrome P450 (CYP3A) enzymes are crucial for drug metabolism across species.
Limited data exists on CYP3A expression and activity in broiler chickens.
Understanding broiler CYP3A is vital for drug efficacy and safety in poultry.

Purpose of the Study:

To quantify CYP3A37 gene expression in broiler liver and small intestine.
To assess in vitro CYP3A activity in broiler tissues.
To compare methods for preparing intestinal microsomes for activity assays.

Main Methods:

Developed a RT-PCR assay for broiler CYP3A37 quantification.
Measured CYP3A activity in vitro using midazolam as a substrate.
Compared two protocols for intestinal microsome preparation.

Main Results:

CYP3A37 expression was highest in the jejunum, followed by the ileum, and lowest in the liver.
In vitro CYP3A activity was highest in the duodenum, decreasing towards the ileum, with liver activity comparable to duodenal activity.
Tissue mincing prior to ultracentrifugation was a more suitable method for microsome preparation.

Conclusions:

The small intestine, especially the duodenum and jejunum, plays a significant role in broiler drug metabolism.
CYP3A37 expression and activity patterns suggest regional differences within the broiler gastrointestinal tract.
These findings are critical for optimizing drug administration and understanding drug disposition in broiler chickens.